Literature DB >> 16949285

Solid-phase combinatorial approach for the optimization of soluble epoxide hydrolase inhibitors.

Sung Hee Hwang1, Christophe Morisseau, Zung Do, Bruce D Hammock.   

Abstract

A 192-member library of N,N'-disubstituted urea inhibitors was synthesized by a solid-phase method. The ureas were tested for their inhibitory activities against recombinant human soluble epoxide hydrolase. Simple carbocyclic or para/meta-substituted phenyl groups showed inhibition potencies that were equal to or greater than adamantane-based sEH inhibitors, while the presence of bulky or ionizable groups close to the urea group dramatically decreased their activities.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16949285      PMCID: PMC1904340          DOI: 10.1016/j.bmcl.2006.08.078

Source DB:  PubMed          Journal:  Bioorg Med Chem Lett        ISSN: 0960-894X            Impact factor:   2.823


  23 in total

1.  Soluble epoxide hydrolase regulates hydrolysis of vasoactive epoxyeicosatrienoic acids.

Authors:  Z Yu; F Xu; L M Huse; C Morisseau; A J Draper; J W Newman; C Parker; L Graham; M M Engler; B D Hammock; D C Zeldin; D L Kroetz
Journal:  Circ Res       Date:  2000-11-24       Impact factor: 17.367

2.  Development of a high-throughput screen for soluble epoxide hydrolase inhibition.

Authors:  Nicola M Wolf; Christophe Morisseau; Paul D Jones; Bertold Hock; Bruce D Hammock
Journal:  Anal Biochem       Date:  2006-05-11       Impact factor: 3.365

Review 3.  Epoxide hydrolases: biochemistry and molecular biology.

Authors:  A J Fretland; C J Omiecinski
Journal:  Chem Biol Interact       Date:  2000-12-01       Impact factor: 5.192

Review 4.  Cytochrome P450 and arachidonic acid bioactivation. Molecular and functional properties of the arachidonate monooxygenase.

Authors:  J H Capdevila; J R Falck; R C Harris
Journal:  J Lipid Res       Date:  2000-02       Impact factor: 5.922

5.  Soluble epoxide hydrolase inhibition lowers arterial blood pressure in angiotensin II hypertension.

Authors:  John D Imig; Xueying Zhao; Jorge H Capdevila; Christophe Morisseau; Bruce D Hammock
Journal:  Hypertension       Date:  2002-02       Impact factor: 10.190

6.  Structural refinement of inhibitors of urea-based soluble epoxide hydrolases.

Authors:  Christophe Morisseau; Marvin H Goodrow; John W Newman; Craig E Wheelock; Deanna L Dowdy; Bruce D Hammock
Journal:  Biochem Pharmacol       Date:  2002-05-01       Impact factor: 5.858

7.  Leukotoxin-diol: a putative toxic mediator involved in acute respiratory distress syndrome.

Authors:  J Zheng; C G Plopper; J Lakritz; D H Storms; B D Hammock
Journal:  Am J Respir Cell Mol Biol       Date:  2001-10       Impact factor: 6.914

8.  Design, synthesis, and biological activity of 1,3-disubstituted ureas as potent inhibitors of the soluble epoxide hydrolase of increased water solubility.

Authors:  In-Hae Kim; Christophe Morisseau; Takaho Watanabe; Bruce D Hammock
Journal:  J Med Chem       Date:  2004-04-08       Impact factor: 7.446

9.  Anandamide and arachidonic acid use epoxyeicosatrienoic acids to activate TRPV4 channels.

Authors:  Hiroyuki Watanabe; Joris Vriens; Jean Prenen; Guy Droogmans; Thomas Voets; Bernd Nilius
Journal:  Nature       Date:  2003-07-24       Impact factor: 49.962

Review 10.  Cytosolic epoxide hydrolase.

Authors:  J Meijer; J W DePierre
Journal:  Chem Biol Interact       Date:  1988       Impact factor: 5.192

View more
  17 in total

Review 1.  Discovery of inhibitors of soluble epoxide hydrolase: a target with multiple potential therapeutic indications.

Authors:  Hong C Shen; Bruce D Hammock
Journal:  J Med Chem       Date:  2012-01-17       Impact factor: 7.446

2.  Salicylate-urea-based soluble epoxide hydrolase inhibitors with high metabolic and chemical stabilities.

Authors:  Takeo Kasagami; In-Hae Kim; Hsing-Ju Tsai; Kosuke Nishi; Bruce D Hammock; Christophe Morisseau
Journal:  Bioorg Med Chem Lett       Date:  2009-01-27       Impact factor: 2.823

3.  Pharmacokinetic screening of soluble epoxide hydrolase inhibitors in dogs.

Authors:  Hsing-Ju Tsai; Sung Hee Hwang; Christophe Morisseau; Jun Yang; Paul D Jones; Takeo Kasagami; In-Hae Kim; Bruce D Hammock
Journal:  Eur J Pharm Sci       Date:  2010-03-30       Impact factor: 4.384

Review 4.  The lipophilic bullet hits the targets: medicinal chemistry of adamantane derivatives.

Authors:  Lukas Wanka; Khalid Iqbal; Peter R Schreiner
Journal:  Chem Rev       Date:  2013-02-25       Impact factor: 60.622

5.  Therapeutic activity of inhibition of the soluble epoxide hydrolase in a mouse model of scrapie.

Authors:  Giorgio Poli; Erica Corda; Piera Anna Martino; Paola Dall'ara; Silvio R Bareggi; Giampietro Bondiolotti; Barbara Iulini; Maria Mazza; Cristina Casalone; Sung Hee Hwang; Bruce D Hammock; Bora Inceoglu
Journal:  Life Sci       Date:  2013-05-05       Impact factor: 5.037

6.  Exploring the size of the lipophilic unit of the soluble epoxide hydrolase inhibitors.

Authors:  Sandra Codony; Elena Valverde; Rosana Leiva; José Brea; M Isabel Loza; Christophe Morisseau; Bruce D Hammock; Santiago Vázquez
Journal:  Bioorg Med Chem       Date:  2019-08-26       Impact factor: 3.641

7.  Heme Binding Biguanides Target Cytochrome P450-Dependent Cancer Cell Mitochondria.

Authors:  Zhijun Guo; Irina F Sevrioukova; Ilia G Denisov; Xia Zhang; Ting-Lan Chiu; Dafydd G Thomas; Eric A Hanse; Rebecca A D Cuellar; Yelena V Grinkova; Vanessa Wankhede Langenfeld; Daniel S Swedien; Justin D Stamschror; Juan Alvarez; Fernando Luna; Adela Galván; Young Kyung Bae; Julia D Wulfkuhle; Rosa I Gallagher; Emanuel F Petricoin; Beverly Norris; Craig M Flory; Robert J Schumacher; M Gerard O'Sullivan; Qing Cao; Haitao Chu; John D Lipscomb; William M Atkins; Kalpna Gupta; Ameeta Kelekar; Ian A Blair; Jorge H Capdevila; John R Falck; Stephen G Sligar; Thomas L Poulos; Gunda I Georg; Elizabeth Ambrose; David A Potter
Journal:  Cell Chem Biol       Date:  2017-09-14       Impact factor: 8.116

8.  1-Aryl-3-(1-acylpiperidin-4-yl)urea inhibitors of human and murine soluble epoxide hydrolase: structure-activity relationships, pharmacokinetics, and reduction of inflammatory pain.

Authors:  Tristan E Rose; Christophe Morisseau; Jun-Yan Liu; Bora Inceoglu; Paul D Jones; James R Sanborn; Bruce D Hammock
Journal:  J Med Chem       Date:  2010-10-14       Impact factor: 7.446

9.  The molecular structure of epoxide hydrolase B from Mycobacterium tuberculosis and its complex with a urea-based inhibitor.

Authors:  Bichitra K Biswal; Christophe Morisseau; Grace Garen; Maia M Cherney; Craig Garen; Chunying Niu; Bruce D Hammock; Michael N G James
Journal:  J Mol Biol       Date:  2008-06-17       Impact factor: 5.469

10.  1,3-disubstituted ureas functionalized with ether groups are potent inhibitors of the soluble epoxide hydrolase with improved pharmacokinetic properties.

Authors:  In-Hae Kim; Hsing-Ju Tsai; Kosuke Nishi; Takeo Kasagami; Christophe Morisseau; Bruce D Hammock
Journal:  J Med Chem       Date:  2007-09-26       Impact factor: 7.446

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.